By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
PR Newswire CRANBURY, N.J., Feb. 10, 2025 CRANBURY, N.J., Feb. 10, 2025 /PRNewswire/ -- IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced ...
PR Newswire TOKYO, Jan. 30, 2025 TOKYO, Jan. 30, 2025 /PRNewswire/ -- Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys Pharma") announced today that it has completed patient enrollment for its registrational Phase III clinical ...
PR Newswire STUART, Fla., Jan. 21, 2025 STUART, Fla., Jan. 21, 2025 /PRNewswire/ -- Stuart Therapeutics, Inc. (Stuart), a clinical-stage drug platform company developing novel therapies for ophthalmic diseases, today announced last patient ...
PR Newswire CONCORD, Mass., Jan. 9, 2025 Pivotal Phase 3 Data Met Pre-defined Outcomes - Achieving a Clinical Response by Day 15 and Clinical Remission by Day 29 On Track for NDA Submission in Q1 2025 CONCORD, Mass., Jan. 9, 2025 ...
PR Newswire UTRECHT, Netherlands, Jan. 8, 2025 Fair Therapeutics B.V. has completed enrollment of its Phase IIb CHOICES trial, evaluating the novel CFTR triple modulator therapy, Diponecaftor, for adults with ultra-rare cystic fibrosis (CF) ...
PR Newswire LOS ANGELES, Jan. 7, 2025 Research highlights need to expand PLD eligibility criteria to reflect real world data LOS ANGELES, Jan. 7, 2025 /PRNewswire/ -- Real-world data from the largest U.S. Lyme disease registry, ...
PR Newswire SILVER SPRING, Md., Jan. 6, 2025 SILVER SPRING, Md., Jan. 6, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued a draft guidance with the Office for Human Research Protections that, when finalized, will ...
PR Newswire WUHAN, China, Jan. 2, 2025 WUHAN, China, Jan. 2, 2025 /PRNewswire/ -- Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet medical ...
PR Newswire NANTONG and SUZHOU, China, Dec. 24, 2024 NANTONG and SUZHOU, China, Dec. 24, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies, today ...
PR Newswire CAMBRIDGE, Mass., Dec. 18, 2024 CAMBRIDGE, Mass., Dec. 18, 2024 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced positive ...
The FDA has given approval for the first clinical trials of pig kidney transplants in humans, representing a significant advancement in addressing the organ shortage crisis.
Clinical trial seeks to enhance hip fracture care for older adults, focusing on better recovery, mobility, and outcomes through advanced treatments and strategies.
A new clinical trial explores whether targeted steam therapy can offer a less invasive, effective treatment for prostate cancer.
Vanderbilt’s Phase I trial of VU319 demonstrates promising results for Alzheimer’s and schizophrenia
Late-breaking research finds no survival benefit from autologous stem cell transplant in mantle cell lymphoma patients with undetectable MRD.
Subscribe to our Free Newsletters!